Should bare metal stents be favored over drug eluting stents for pregnant patients presenting with acute coronary syndrome?

This is a great question.

There is limited data that supports the safe use of DES in pregnant patients requiring revascularization (Regitz-Zagrosek et al., PMID 30165544). New-generation DES has a lower risk of stent thrombosis with shorter or even very short duration (28 days) of dual antiplatelet ...